Hikma Pharmaceuticals PLC 2024 SR

The report highlights Hikma Pharmaceuticals' sustainability progress in 2024, focusing on advancing health and wellbeing through increased access to high-quality medicines. The company conducted a comprehensive Double Materiality Assessment (DMA) aligned with CSRD and ESRS standards to refine its sustainability framework. Key achievements include treating 262 million patients globally and achieving a 17% reduction in Scope 1 and 2 emissions compared to the 2020 baseline. Hikma also emphasized employee empowerment, reporting a 73% engagement score and significant investments in community health and education programs.

Company: Hikma Pharmaceuticals PLC

Sector: Health Care

Country: United Kingdom

Year: 2024

Type: SR

Pages: 53

Back to company

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC 2024 Sustainability Report

Sustainability Report

The report highlights Hikma Pharmaceuticals' sustainability progress in 2024, focusing on advancing health and wellbeing through increased access to high-quality medicines. The company conducted a comprehensive Double Materiality Assessment (DMA) aligned with CSRD and ESRS standards to refine its sustainability framework. Key achievements include treating 262 million patients globally and achieving a 17% reduction in Scope 1 and 2 emissions compared to the 2020 baseline. Hikma also emphasized employee empowerment, reporting a 73% engagement score and significant investments in community health and education programs.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

Sustainable Development Goals

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Employees